• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同种族人群的绝经前血管舒缩症状

Premenopausal vasomotor symptoms in an ethnically diverse population.

作者信息

Reed Susan D, Lampe Johanna W, Qu Conghui, Copeland Wade K, Gundersen Gabrielle, Fuller Sharon, Newton Katherine M

机构信息

From the 1Group Health Research Institute, University of Washington, Seattle, WA; and 2Fred Hutchinson Cancer Research Center, Seattle, WA.

出版信息

Menopause. 2014 Feb;21(2):153-8. doi: 10.1097/GME.0b013e3182952228.

DOI:10.1097/GME.0b013e3182952228
PMID:23760434
Abstract

OBJECTIVE

The prevalence of vasomotor symptoms (VMS) among women aged 45 years or older who report regular menses has not been described well. Variability by race/ethnicity is expected.

METHODS

A cross-sectional analysis of Group Health enrollees was performed among women ages 45-56 y with regular and no skipped menses, and not taking hormones. Data were collected from electronic databases and mailed surveys, including a soy food questionnaire. Associations between race/ethnicity and VMS (ever/never; past 2 wk) were assessed using generalized linear models, controlling for age and body mass index. The prevalence of headache and joint pain, and VMS associations within race by soy intake were explored.

RESULTS

A total of 1,513 premenopausal women with a mean age of 48.5 years responded to the survey; 75% were white. Native American women were most likely to report ever having VMS (66.7%), followed by black (61.4%), white (58.3%), Hawaiian/Pacific Islander (45.5%), mixed-ethnicity (42.1%), Vietnamese (40.0%), Filipino (38.9%, P < 0.05), Japanese (35.9%, P < 0.01), East Indian (31.3%, P < 0.05), Chinese (29.0%, P < 0.001), and other Asian (25.6%, P < 0.001) women, as compared with white women. Hispanic women were less likely to have VMS (41.7%) than non-Hispanic white women (58.8%, P < 0.001). Among white women, but not among other women, soy intake was associated with VMS (P = 0.03).

CONCLUSIONS

Among a diverse population of premenopausal women, VMS prevalence is high at 55%. Asian (vs white) and Hispanic (vs non-Hispanic white) women are less likely to report ever having VMS, a pattern similar to that observed during the menopausal transition and early postmenopause in our studies. White women with more VMS seem to include more soy in their diet.

摘要

目的

45岁及以上有规律月经的女性血管舒缩症状(VMS)的患病率尚未得到充分描述。预计种族/民族之间存在差异。

方法

对健康集团的参保者进行横断面分析,研究对象为45至56岁有规律月经且无月经跳过、未服用激素的女性。数据从电子数据库和邮寄调查问卷中收集,包括一份大豆食品问卷。使用广义线性模型评估种族/民族与VMS(曾经/从未;过去2周)之间的关联,并控制年龄和体重指数。探讨头痛和关节痛的患病率,以及按大豆摄入量划分的种族内部VMS的关联。

结果

共有1513名平均年龄为48.5岁的绝经前女性对调查做出了回应;75%为白人。美国原住民女性报告曾有VMS的可能性最高(66.7%),其次是黑人(61.4%)、白人(58.3%)、夏威夷/太平洋岛民(45.5%)、混合种族(42.1%)、越南人(40.0%)、菲律宾人(38.9%,P<0.05)、日本人(35.9%,P<0.01)、东印度人(31.3%,P<0.05)、中国人(29.0%,P<0.001)和其他亚洲人(25.6%,P<0.001)女性,与白人女性相比。西班牙裔女性出现VMS的可能性(41.7%)低于非西班牙裔白人女性(58.8%,P<0.001)。在白人女性中,但在其他女性中并非如此,大豆摄入量与VMS相关(P=0.03)。

结论

在不同的绝经前女性群体中,VMS患病率高达55%。亚洲女性(与白人相比)和西班牙裔女性(与非西班牙裔白人相比)报告曾有VMS的可能性较小,这一模式与我们研究中绝经过渡期间和绝经后早期观察到的模式相似。有更多VMS的白人女性在饮食中似乎摄入了更多大豆。

相似文献

1
Premenopausal vasomotor symptoms in an ethnically diverse population.不同种族人群的绝经前血管舒缩症状
Menopause. 2014 Feb;21(2):153-8. doi: 10.1097/GME.0b013e3182952228.
2
Self-reported menopausal symptoms in a racially diverse population and soy food consumption.种族多样化人群的自我报告的绝经期症状与大豆食品的消费。
Maturitas. 2013 Jun;75(2):152-8. doi: 10.1016/j.maturitas.2013.03.003. Epub 2013 Apr 3.
3
Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN).日常歧视是否解释了黑人女性血管舒缩症状风险增加的原因?:妇女健康全国性研究(SWAN)。
Menopause. 2024 Jun 1;31(6):484-493. doi: 10.1097/GME.0000000000002357. Epub 2024 Apr 9.
4
Duration of menopausal vasomotor symptoms over the menopause transition.绝经过渡期间绝经血管舒缩症状的持续时间。
JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.
5
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density.不孕的绝经前女性的血管舒缩症状:骨矿物质密度低的一个迄今未被认识到的风险。
Fertil Steril. 2008 Nov;90(5):1626-34. doi: 10.1016/j.fertnstert.2007.08.020. Epub 2008 Feb 20.
6
Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.绝经过渡期血管舒缩症状与骨转换增加的相关性。
J Bone Miner Res. 2011 Apr;26(4):840-9. doi: 10.1002/jbmr.259.
7
Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review.绝经相关血管舒缩症状与睡眠障碍的全球观察:一项系统性综述。
Climacteric. 2023 Dec;26(6):537-549. doi: 10.1080/13697137.2023.2256658. Epub 2023 Dec 1.
8
Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis.血管舒缩症状的存在与较低的骨矿物质密度相关:一项纵向分析。
Menopause. 2009 Mar-Apr;16(2):239-46. doi: 10.1097/gme.0b013e3181857964.
9
Characterizing the trajectories of vasomotor symptoms across the menopausal transition.描绘绝经过渡期间血管舒缩症状的发展轨迹。
Menopause. 2016 Oct;23(10):1067-74. doi: 10.1097/GME.0000000000000676.
10
Ethnicity and vasomotor symptoms in postmenopausal women.绝经后女性的种族与血管舒缩症状
J Womens Health (Larchmt). 2007 Oct;16(8):1130-8. doi: 10.1089/jwh.2006.0033.

引用本文的文献

1
FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option.美国食品药品监督管理局批准Veozah(非索利那新)用于治疗更年期症状:一种新的非激素疗法选择。
Ann Med Surg (Lond). 2025 Jul 30;87(9):5373-5377. doi: 10.1097/MS9.0000000000003670. eCollection 2025 Sep.
2
Effectiveness of Multisymptom Support for Better Relief and Alleviation of Common Effects in Perimenopause (EMBRACE PERIMENOPAUSE).多症状支持对围绝经期常见症状更好缓解和减轻的有效性(EMBRACE围绝经期)
Cureus. 2025 Jun 15;17(6):e86091. doi: 10.7759/cureus.86091. eCollection 2025 Jun.
3
Indigenous, integrative, and biomedical perimenopause and postmenopause healthcare for Indigenous midlife peoples residing in the United States and Canada: A scoping review.
为居住在美国和加拿大的原住民中年人群提供的围绝经期和绝经后期的本土、综合及生物医学保健:一项范围综述。
medRxiv. 2025 Jul 11:2025.07.10.25331221. doi: 10.1101/2025.07.10.25331221.
4
Evening Primrose Oil for Menopause Hot Flashes: Systematic Review and Meta-Analysis.月见草油治疗更年期潮热:系统评价与荟萃分析
J Menopausal Med. 2024 Dec;30(3):127-134. doi: 10.6118/jmm.23038.
5
Menopausal hormone therapy use among active duty service women.现役女性军人中更年期激素疗法的使用情况。
Menopause. 2025 Feb 1;32(2):128-133. doi: 10.1097/GME.0000000000002469. Epub 2024 Dec 24.
6
Revolutionary treatment for menopausal symptoms: Veozah (Fezolinetant) receives FDA approval.更年期症状的革命性治疗方法:Veozah(非佐利坦)获得美国食品药品监督管理局批准。
Ann Med Surg (Lond). 2024 Jan 4;86(12):6905-6907. doi: 10.1097/MS9.0000000000001659. eCollection 2024 Dec.
7
Developing a Menopausal Transition Health Promotion Intervention With Indigenous, Integrative, and Biomedical Health Education: A Community-Based Approach With Urban American Indian/Alaska Native Women.开发一种包含本土、综合及生物医学健康教育的围绝经期健康促进干预措施:一种针对美国城市印第安/阿拉斯加原住民女性的社区方法。
Glob Adv Integr Med Health. 2024 Aug 13;13:27536130241268232. doi: 10.1177/27536130241268232. eCollection 2024 Jan-Dec.
8
From maca to marijuana: cultural influences on joint pain symptoms and management in urban perimenopausal and early postmenopausal Latinas.从玛卡到大麻:城市围绝经期和绝经早期拉丁裔女性关节痛症状和管理的文化影响。
Menopause. 2024 Sep 1;31(9):756-763. doi: 10.1097/GME.0000000000002396. Epub 2024 Jul 29.
9
Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN).日常歧视是否解释了黑人女性血管舒缩症状风险增加的原因?:妇女健康全国性研究(SWAN)。
Menopause. 2024 Jun 1;31(6):484-493. doi: 10.1097/GME.0000000000002357. Epub 2024 Apr 9.
10
Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2).非佐利奈坦治疗绝经相关中重度血管舒缩症状:两项 3 期研究(SKYLIGHT 1 和 2)中内在和外在因素的影响。
Menopause. 2024 Apr 1;31(4):247-257. doi: 10.1097/GME.0000000000002340.